Filing Details
- Accession Number:
- 0001213900-22-075598
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-28 18:27:58
- Reporting Period:
- 2022-11-23
- Accepted Time:
- 2022-11-28 18:27:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 316253 | Enzo Biochem Inc | ENZ | Services-Medical Laboratories (8071) | 132866202 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1893172 | Hamid Erfanian | C/O Enzo Biochem, Inc 81 Executive Blvd., Suite 3 Farmingdale NY 11735 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2022-11-23 | 100,000 | $1.97 | 374,600 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (to acquire Common Stock) | Acquisiton | 2022-11-23 | 300,000 | $0.00 | 300,000 | $1.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 300,000 | 2023-11-23 | 2027-11-23 | No | 4 | A | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (to acquire Common Stock) | $3.39 | 2022-11-08 | 2026-11-08 | 700,000 | 700,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2026-11-08 | 700,000 | 700,000 | Direct |
Footnotes
- The Reporting Person was granted Restricted Stock Units that will vest in three equal installments, beginning on November 23, 2023.
- The Reporting Person was granted 300,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 23, 2023.
- The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.
Billionaire Hedge Funds
